Incremental Cost Effectiveness Ratios [ICER] (Incremental cost rTMS vs. pharmacotherapy divided by the incremental benefit rTMS vs. pharmacotherapy)–assuming upper end of the number of treatments in order to have a response to rTMS and; assuming the cost of pharmacotherapy @ ~$100/month.
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
https://figshare.com/articles/dataset/Incremental_Cost_Effectiveness_Ratios_ICER_Incremental_cost_rTMS_vs_pharmacotherapy_divided_by_the_incremental_benefit_rTMS_vs_pharmacotherapy_assuming_upper_end_of_the_number_of_treatments_in_order_to_have_a_response_to_rTMS_and_assuming_the_cost_of_phar/5542459数据链接链接失效反馈
官方服务：
资源简介：
Incremental Cost Effectiveness Ratios [ICER] (Incremental cost rTMS vs. pharmacotherapy divided by the incremental benefit rTMS vs. pharmacotherapy)–assuming upper end of the number of treatments in order to have a response to rTMS and; assuming the cost of pharmacotherapy @ ~$100/month.
创建时间：
2017-10-27
